{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-029187","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2025-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.931775+00:00","generated_at":"2026-05-26T12:38:37.325940+00:00","sec_items":["2.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Stryker completes $4.94B cash acquisition of Inari Medical","bullets":["Closed acquisition of Inari Medical for ~$4.94 billion in cash on Feb 19, 2025.","Merger was effected via merger of Stryker subsidiary with Inari; Inari continues as surviving corporation.","Transaction previously announced under Jan 6, 2025 Merger Agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-029187","json":"https://secwatch.observer/filing/0001193125-25-029187.json","markdown":"https://secwatch.observer/filing/0001193125-25-029187.md","text":"https://secwatch.observer/filing/0001193125-25-029187.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000119312525029187/0001193125-25-029187-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000119312525029187/d934806d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T12:38:37.325940+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e420f0741fd122bcf7ab633edec8590571379e14","claim":"STRYKER CORP completed an acquisition involving Inari Medical, Inc. for approximately $4.94 billion in cash (closed 2025-02-19).","evidence_excerpt":"with Inari continuing as the surviving corporation. The total aggregate consideration paid by or on behalf of Stryker and Merger Sub in the transaction was approximately $4.94 billion in cash. The foregoing description of the Merger Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Merger","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/310764/000119312525029187/0001193125-25-029187-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Inari Medical, Inc."},{"label":"Consideration","value":"approximately $4.94 billion in cash"},{"label":"Closing","value":"2025-02-19"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}